- 4.8Impact Factor
- 9.2CiteScore
- 20 daysTime to First Decision
Biomolecules, Volume 13, Issue 4
April 2023 - 140 articles
Cover Story: Rett syndrome (RTT) is a severe neurodevelopmental disorder characterized by motor and cognitive disabilities, the pathogenetic mechanisms of which remain to be fully elucidated. RTT is caused by mutations in MECP2, an epigenetic factor crucial for brain functioning. We found, in the brains of Mecp2-null mice, enhanced BBB permeability and the aberrant expression of the tight junction proteins Ocln and Cldn-5. Moreover, the Cldn3, Cldn12, Mpdz, Jam2, and Aqp4 genes, encoding factors with a role in the BBB structure and function, showed altered expressions in Mecp2-null brains. This study provides the first evidence of impaired BBB integrity in RTT and highlights a potential new molecular hallmark of the disease that might open new perspectives for the setting-up of novel therapeutic strategies. View this paper
- Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
- You may sign up for email alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Articles
There are no articles in this issue yet.

